Arkolith/Insider Trading/TSHA/Form 4

Manning Paul B

10% OwnerTaysha Gene Therapies, Inc. (TSHA) · full profile →Form 4 · filed Nov 20, 2023
Net Buying
Open-Market Buys
$163K
Open-Market Sells
$0
Net Open-Market Flow
$163K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2023Buy(P)100K$1.63$163K16.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-055942) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML